Astellas Pharma Inc. (ALPMF)
OTC: ALPMF
· Real-Time Price · USD
11.10
0.00 (0.00%)
At close: Aug 08, 2025, 2:03 PM
Astellas Pharma Revenue
Astellas Pharma reported an annual revenue of $1,912.3B, reflecting a 19.25% growth. For the quarter ending March 31, 2025, Astellas Pharma generated $459.29B in revenue.
Revenue (ttm)
1,912.3B
Revenue Growth
19.25%
Price / Sales Ratio
1.37
Revenue / Employee
129.61M
Employees
14,754
Market Cap
19.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2025 | 1,912.3B | +19.25% |
| Mar 31, 2024 | 1,603.7B | +5.60% |
| Mar 31, 2023 | 1,518.6B | +17.16% |
| Mar 31, 2022 | 1,296.2B | +3.73% |
| Mar 31, 2021 | 1,249.5B | -3.94% |
| Mar 31, 2020 | 1,300.8B | n/a |